Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
RG-6315 by Genentech USA for Fibrosis: Likelihood of Approval
RG-6315 is under clinical development by Genentech USA and currently in Phase I for Fibrosis. According to GlobalData, Phase I...
Data Insights
RG-6315 by Genentech USA for Inflammation: Likelihood of Approval
RG-6315 is under clinical development by Genentech USA and currently in Phase I for Inflammation. According to GlobalData, Phase I...